Search Results - "White, Jennifer S."

Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing by Wolcott, Randall D., Hanson, John D., Rees, Eric J., Koenig, Lawrence D., Phillips, Caleb D., Wolcott, Richard A., Cox, Stephen B., White, Jennifer S.

“…The extent to which microorganisms impair wound healing is an ongoing controversy in the management of chronic wounds. Because the high diversity and extreme…”
Get full text

Barriers and facilitators to resuming meaningful daily activities among critical illness survivors in the UK: a qualitative content analysis by Scheunemann, Leslie, White, Jennifer S, Prinjha, Suman, Eaton, Tammy L, Hamm, Megan, Girard, Timothy D, Reynolds, Charles, Leland, Natalie, Skidmore, Elizabeth R

“…ObjectiveTo identify critical illness survivors’ perceived barriers and facilitators to resuming performance of meaningful activities when transitioning from…”
Get full text

Exploring Occupational Therapists' Experiences in U.S. Primary Care Settings: A Qualitative Study by Rouch, Stephanie A, Klinedinst, Tara C, White, Jennifer S, Leland, Natalie E

“…Occupational therapy's scope of practice aligns with the goals of comprehensive primary care set forth by the 2010 Patient Protection and Affordable Care Act…”
Get more information

Post-Intensive Care Unit Care. A Qualitative Analysis of Patient Priorities and Implications for Redesign by Scheunemann, Leslie P, White, Jennifer S, Prinjha, Suman, Hamm, Megan E, Girard, Timothy D, Skidmore, Elizabeth R, Reynolds, 3rd, Charles F, Leland, Natalie E

“…Although survival during critical illness is improving, little evidence exists to guide post-intensive care unit (ICU) care. Understanding patients' needs and…”
Get full text

Results of a reevaluation of cardiovascular outcomes in the RECORD trial by Mahaffey, Kenneth W., MD, Hafley, Gail, MS, Dickerson, Sheila, RN, Burns, Shana, BS, Tourt-Uhlig, Sandra, RN, White, Jennifer, MS, Newby, L. Kristin, MD, Komajda, Michel, MD, McMurray, John, MD, Bigelow, Robert, PhD, Home, Philip D., DM, Lopes, Renato D., MD, PhD

“…Background The US Food and Drug Administration (FDA) required a reevaluation of cardiovascular (CV) outcomes in the RECORD trial. This provided an opportunity…”
Get full text

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention by Bohula, Erin A., MD, DPhil, Morrow, David A., MD, MPH, Giugliano, Robert P., MD, SM, Blazing, Michael A., MD, He, Ping, MS, Park, Jeong-Gun, PhD, Murphy, Sabina A., MPH, White, Jennifer A., MS, Kesaniemi, Y. Antero, MD, PhD, Pedersen, Terje R., MD, PhD, Brady, Adrian J., MD, Mitchel, Yale, MD, Cannon, Christopher P., MD, Braunwald, Eugene, MD

“…Abstract Background Ezetimibe improves cardiovascular (CV) outcomes in patients stabilized after acute coronary syndrome (ACS) when added to statin therapy…”
Get full text

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends by Tricoci, Pierluigi, MD, MHS, PhD, Leonardi, Sergio, MD, MHS, White, Jennifer, MS, White, Harvey D., MB, ChB, DSc, Armstrong, Paul W., MD, Montalescot, Gilles, MD, Giugliano, Robert P., MD, SM, Gibson, C. Michael, MD, Van de Werf, Frans, MD, Califf, Robert M., MD, Harrington, Robert A., MD, Braunwald, Eugene, MD, Mahaffey, Kenneth W., MD, Newby, L. Kristin, MD, MHS

“…Objectives This study sought to review cardiac troponin (cTn) trends during non–ST-segment elevation acute coronary syndrome (NSTE ACS) in patients undergoing…”
Get full text

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population by Blazing, Michael A., MD, Giugliano, Robert P., MD, SM, Cannon, Christopher P., MD, Musliner, Thomas A., MD, Tershakovec, Andrew M., MD, MPH, White, Jennifer A., MS, Reist, Craig, PhD, McCagg, Amy, BS, Braunwald, Eugene, MD, Califf, Robert M., MD

“…Background The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) is evaluating the potential benefit for reduction in major…”
Get full text

Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction by Rao, Sunil V., MD, Zeymer, Uwe, MD, Douglas, Pamela S., MD, Al-Khalidi, Hussein, PhD, White, Jennifer A., MS, Liu, Jingyu, PhD, Levy, Howard, MD, PhD, Guetta, Victor, MD, Gibson, C. Michael, MD, Tanguay, Jean-Francois, MD, Vermeersch, Paul, MD, Roncalli, Jérôme, MD, PhD, Kasprzak, Jaroslaw D., MD, Henry, Timothy D., MD, Frey, Norbert, MD, Kracoff, Oscar, MD, Traverse, Jay H., MD, Chew, Derek P., MBBS, Lopez-Sendon, Jose, MD, Heyrman, Reinilde, MD, Krucoff, Mitchell W., MD

“…Abstract Background Bioabsorbable cardiac matrix (BCM) is a novel device that attenuates adverse left ventricular (LV) remodeling after large myocardial…”
Get full text

Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct by Lopes, Renato D., MD, PhD, Dickerson, Sheila, RN, Hafley, Gail, MS, Burns, Shana, BS, Tourt-Uhlig, Sandra, RN, White, Jennifer, MS, Newby, L. Kristin, MD, Komajda, Michel, MD, McMurray, John, MD, Bigelow, Robert, PhD, Home, Philip D., DM, Mahaffey, Kenneth W., MD

“…Background In 2010, after regulatory review of rosiglitazone licensing, the US Food and Drug Administration (FDA) requested a reevaluation of cardiovascular…”
Get full text

Outpatient thyroid surgery: Safety of an optimized protocol in more than 1,000 patients by Segel, Jamie M., MD, Duke, William S., MD, White, Jennifer R., BS, Waller, Jennifer L., PhD, Terris, David J., MD, FACS

“…Objectives Outpatient thyroid surgery is becoming increasingly common. The aim of this study was to clarify the principles for safe outpatient thyroid surgery…”
Get full text

On-Treatment Analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) by Blazing, Michael A., MD, Giugliano, Robert P., MD, SM, de Lemos, James A., MD, Cannon, Christopher P., MD, Tonkin, Andrew, MBBS, MD, Ballantyne, Christie M., MD, Lewis, Basil S., MD, Musliner, Thomas A., MD, Tershakovec, Andrew M., MD, MPH, Lokhnygina, Yuliya, PhD, White, Jennifer A., MS, Reist, Craig, PhD, McCagg, Amy, BS, Braunwald, Eugene, MD

“…Abstract Background We aimed to determine the efficacy and safety of adding ezetimibe (Ez) to simvastatin (S) in a post-acute coronary syndrome (ACS)…”
Get full text

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome by Murphy, Sabina A., MPH, Cannon, Christopher P., MD, Blazing, Michael A., MD, Giugliano, Robert P., MD, White, Jennifer A., MS, Lokhnygina, Yuliya, PhD, Reist, Craig, PhD, Im, KyungAh, PhD, Bohula, Erin A., MD, DPhil, Isaza, Daniel, MD, Lopez-Sendon, Jose, MD, Dellborg, Mikael, MD, Kher, Uma, PhD, Tershakovec, Andrew M., MD, MPH, Braunwald, Eugene, MD

“…Abstract Background Intensive low-density lipoprotein cholesterol therapy with ezetimibe/simvastatin in IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin…”
Get full text

Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock by Singh, Mandeep, MD, White, Jennifer, MS, Hasdai, David, MD, Hodgson, Patricia K., BA, Berger, Peter B., MD, Topol, Eric J., MD, Califf, Robert M., MD, Holmes, David R., MD

“…Long-Term Outcome and Its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock: Insights From the GUSTO-I Trial…”
Get full text

Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non–ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome trial by Bagai, Akshay, MD MHS, White, Jennifer A., MS, Lokhnygina, Yuliya, PhD, Giugliano, Robert P., MD, Van de Werf, Frans, MD, Montalescot, Gilles, MD, Armstrong, Paul W., MD, Tricoci, Pierluigi, MD, PhD, MHS, Gibson, C. Michael, MD, Califf, Robert M., MD, Harrington, Robert A., MD, Newby, L. Kristin, MD, MHS

“…Aims In the EARLY ACS trial, routine early eptifibatide was not superior to delayed provisional use at percutaneous coronary intervention (PCI); however, among…”
Get full text

Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function by Melloni, Chiara, MD, MHS, James, Stefan K., MD, PhD, White, Jennifer A., MS, Giugliano, Robert P., MD, SM, Harrington, Robert A., MD, Huber, Kurt, MD, Tricoci, Pierluigi, MD, PhD, MHS, Armstrong, Paul W., MD, Van de Werf, Frans, MD, PhD, Montalescot, Gilles, MD, PhD, Califf, Robert M., MD, Newby, L. Kristin, MD, MHS

“…Background Dose adjustment of renally excreted antithrombotic drugs is recommended for patients with reduced renal function. We examined the influence of dose…”
Get full text